Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 77 P249 | DOI: 10.1530/endoabs.77.P249

SFEBES2021 Poster Presentations Thyroid (23 abstracts)

Pulse methylprednisolone as preparation for thyroidectomy for drug-resistant amiodarone-induced thyrotoxicosis

Krzysztof Lewandowski 1,2 , Katarzyna Dabrowska 2 , Monika Gluchowska 2,3 & Andrzej Lewinski 1,2


1Department of Endocrinology & Metabolic Diseases, The Medical University of Lodz, Lodz, Poland; 2Department of Endocrinology & Metabolic Diseases, "Polish Mother’s" Memorial Hospital Research Institute, Lodz, Poland; 3Department of Pathology of Pregnancy, 1st Chair of Gynaecology and Obstetrics, The Medical University of Lodz, Lodz, Poland


Background: Amiodarone-induced thyrotoxicosis is sometimes extremely difficult to treat necessitating emergency thyroidectomy with perioperative risks including possible thyroid storm. We obtained near normalization of free T3 (FT3) by pulse Methylprednisolone prior to thyroidectomy for drug-resistant Amiodarone-induced thyrotoxicosis.

Case Description: A 56 year old man (BMI 29.7 kg/m2), with history atrial flutter/fibrillation, episodes of fast AF~200/minute, after unsuccessful ablation therapy, presented with severe Amiodarone-induced thyrotoxicosis, unresponsive to high dose oral Thiamazole (40 mg/day). On admission his FT3 was 24.59 pg/ml (ref. range 2.0-4.4), free T4 (FT4)>7.77 ng/dl (ref. range 0.93-1.7), TSH<0.005 uIU/ml. All anti-thyroid antibodies were negative. Thyroid ultrasound revealed normal size thyroid without focal lesions. He initially responded to high dose intravenous Thiamazole (40 mg tds), Lithium Carbonate (250 mg tds) and oral Prednisolone (60 mg od) i.e. after 11 days his FT3 was 5.4 pg/ml, FT4 4.96 ng/dl, but after change to oral thiamazole (20 mg tds), there was a rebound increase of FT3 (to 9.6 pg/ml), and FT4 (to 6.14 ng/dl). Re-administration of intravenous Thiamazole prevented an increase in FT3, but there was further increase in FT4 (>7.77 ng/dl). On 24th day of admission he was therefore referred for emergency thyroidectomy. Administration of 500 mg of intravenous Methylprednisolone (on a background of oral Prednisolone) within 48 hours resulted in a decrease in FT3 from 9.53 pg/ml to 6.03 pg/ml (2.0-4.4) i.e. only 37% above upper reference range. Following administration of two units of fresh frozen plasma (in order to enhance further thyroid hormone binding) he underwent successful total thyroidectomy (9 days post-surgery: TSH 0.005 uIU/ml, FT3 0.99 pg/ml, FT4 1.16 ng/dl).

Conclusions: Pulse intravenous Methylprednisolone may be a useful adjunct therapy for preparation for thyroidectomy in cases of drug-resistant Amiodarone-induced thyrotoxicosis.

Volume 77

Society for Endocrinology BES 2021

Edinburgh, United Kingdom
08 Nov 2021 - 10 Nov 2021

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.